Fermenta Biotech Ltd.
Snapshot View

184.00 -3.35 ▼-1.8%

02 December 2022, 04:01:00 PM
Volume: 11,355

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.fermentabiotech.com
Market Cap 543.44 Cr.
Enterprise Value(EV) 743.67 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) -3.64 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-09
Industry PE 35.40 Trailing Twelve Months Ending 2022-09
Book Value / Share 121.80 Trailing Twelve Months Ending 2022-09
Price to Book Value 1.51 Calculated using Price: 184.00
Dividend Yield 0.68 Period Ending 2022-03
No. of Shares Subscribed 2.94 Cr. 29,430,987 Shares
FaceValue 5
Company Profile
Currently, DIL is engaged in the business of research support services through its subsidiary Research Support International Ltd. (RSIL), manufacture and marketing of enzymes and chemicals through its subsidiary Fermenta Biotech Ltd. (FBL), entertainment through its subsidiary White Stripes Entertainment Ltd. (WSEL) and manufacture and marketing of levitation technology and wheel chairs through its Joint Venture company, being set up in the Czech Republic.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-1.79%
1 Week
+0.85%
1 Month
-5.86%
3 Month
-10.81%
6 Month
-14.46%
1 Year
-38.33%
2 Year
-40.11%
5 Year
+30.64%
10 Year
+276.36%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 8.47 0.72 2.08 -6.00 40.79 64.77 21.92 13.05 4.27
Return on Capital Employed (%) 10.54 3.68 6.18 1.96 33.86 40.16 12.98 12.62 7.50
Return on Assets (%) 4.55 0.37 0.99 -2.76 15.85 25.73 10.75 6.56 2.04

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 133 132 130 144 124 251 309 361 372 358
Non Curr. Liab. 33 14 24 48 146 125 72 131 154 112
Curr. Liab. 71 94 108 86 104 156 195 230 228 203
Minority Int. 22 22 26 28 11 0 0 0 -1 -1
Equity & Liab. 259 262 288 307 385 532 576 722 753 671
Non Curr. Assets 145 171 195 203 202 226 292 391 419 367
Curr. Assets 114 91 93 104 182 296 284 330 335 304
Misc. Exp. not W/O 10
Total Assets 259 262 288 307 385 532 576 722 753 671

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 139 142 155 164 303 405 293 377 399 379
Other Income 3 0 1 3 11 27 14 8 8 11
Total Income 142 142 156 167 314 431 307 386 407 390
Total Expenditure -113 -126 -135 -152 -212 -269 -229 -295 -336 -351
PBIDT 30 16 21 15 102 162 79 91 70 39
Interest -5 -5 -6 -10 -14 -21 -20 -19 -18 -18
Depreciation -10 -9 -8 -10 -12 -12 -15 -20 -26 -29
Taxation -3 -2 -4 -3 -21 -11 16 -9 -12 -4
Exceptional Items
PAT 11 1 3 -8 55 118 60 43 15 -12
Minority Interest -2 0 -3 -3 -13 0 0 3 0 1
Share Associate -1 0 -1 0 -8 0
Other Related Items
Consolidated Net Profit 8 0 -1 -11 34 117 60 46 15 -11
Adjusted EPS 3 0 0 -4 12 43 21 16 5 -4

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 23 14 15 4 2 59 90 34 63 43
Cash Fr. Inv. -20 -25 -18 -13 7 -101 -97 -44 -42 -26
Cash Fr. Finan. -8 13 1 10 -12 89 12 -47 -1 -22
Net Change -4 2 -2 1 -4 47 6 -57 20 -4
Cash & Cash Eqvt 4 6 3 5 -15 32 38 -18 2 -2

Shareholding Pattern View Details >>

9 Qtrs 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%)
Promoter 59.44 59.44 59.44 59.44 59.44 59.58 59.58 59.58 59.58
Public 40.55 40.56 40.56 40.56 40.55 40.42 40.41 40.42 40.41
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 02 Dec 2022
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we inform you that the Company has received information from the shareholder about loss of share certificates on December 2 2022
Wed, 23 Nov 2022
Related Party Transactions Under Regulation 23 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
In connection with our earlier intimation dated November 11 2022 regarding the Outcome of the Board Meetingfor approval of the Unaudited Financial Results (Standalone and Consolidated) for the quarter and half yearended September 30 2022 and in accordance with Regulation 23 of Listing Regulations we are enclosingherewith the disclosure of Related Party Transactions for the half year ended September 30 2022.This information will also be made available at https://fermentabiotech.com/stock-exchange-intimation.php
Thu, 17 Nov 2022
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we inform you that the Company has received information from the shareholder about loss of share certificates on November 16 2022

Technical Scans View Details >>

Fri, 02 Dec 2022
High Delivery Percentage High Delivery Percentage
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
High Decrease 1 Month High Decrease 1 Month
High Decrease 3 Months High Decrease 3 Months
High Decrease 1 Year High Decrease 1 Year

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 249,530.84 1,040.00 -0.6%
Cipla Ltd. 89,936.23 1,114.35 -0.9%
Divi's Laboratories Ltd. 89,761.56 3,381.25 -0.8%
Dr. Reddy's Laboratories Ltd. 75,098.21 4,510.40 +0.8%
Apollo Hospitals Enterprise Ltd. 70,043.98 4,871.45 +2.0%
Torrent Pharmaceuticals Ltd. 54,931.39 1,623.05 -1.2%
Max Healthcare Institute Ltd. 43,491.25 448.10 -0.9%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 60.50 1,040.00 -0.6%
Cipla Ltd. Consolidated 2022-09 35.23 1,114.35 -0.9%
Divi's Laboratories Ltd. Consolidated 2022-09 29.99 3,381.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 24.23 4,510.40 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 83.18 4,871.45 +2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 68.92 1,623.05 -1.2%
Max Healthcare Institute Ltd. Consolidated 2022-09 46.09 448.10 -0.9%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.68 1,040.00 -0.6%
Cipla Ltd. Consolidated 2022-09 4.13 1,114.35 -0.9%
Divi's Laboratories Ltd. Consolidated 2022-09 7.40 3,381.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 3.63 4,510.40 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 11.67 4,871.45 +2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 9.02 1,623.05 -1.2%
Max Healthcare Institute Ltd. Consolidated 2022-09 6.29 448.10 -0.9%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 1,040.00 -0.6%
Cipla Ltd. Consolidated 2022-03 0.04 1,114.35 -0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,381.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,510.40 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,871.45 +2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,623.05 -1.2%
Max Healthcare Institute Ltd. Consolidated 2022-03 0.12 448.10 -0.9%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.00 -0.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,114.35 -0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,381.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,510.40 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,871.45 +2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,623.05 -1.2%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 448.10 -0.9%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.00 -0.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,114.35 -0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,381.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,510.40 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,871.45 +2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,623.05 -1.2%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 448.10 -0.9%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,040.00 -0.6%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,114.35 -0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,381.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,510.40 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,871.45 +2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,623.05 -1.2%
Max Healthcare Institute Ltd. Consolidated 2022-03 3,931.46 448.10 -0.9%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,040.00 -0.6%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,114.35 -0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,381.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,510.40 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,871.45 +2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,623.05 -1.2%
Max Healthcare Institute Ltd. Consolidated 2022-03 605.05 448.10 -0.9%

FAQ's On Fermenta Biotech Ltd.

What is Fermenta Biotech share price?

Can I buy Fermenta Biotech shares now?

What is the Dividend Yield of Fermenta Biotech?

What is the Market Cap of Fermenta Biotech?

What are the key metrics to analyse Fermenta Biotech?

What is the 52 Week High and Low of Fermenta Biotech?

What is the trend of Fermenta Biotech share price?